ALGIECEL™ | BioSolutions for Decarbonization
+45 2248 5667
Send e-mail
Application
Vision
BioSolutions for Decarbonization
Mission
We produce tomorrow´s sustainable protein and omega-3 rich products utilizing captured carbon dioxide, microalgae, and a win-win business model.
Our Core Values
Planetary health is in everybody´s interest
Not bound by business as usual
Customer service is in our DNA
Work life balance & ownership mentality
Trust and support
Remember to have fun
THE COMPANY TODAY
of& exhigkrofromfroALGIECEL was founded in Q2 2021 by CEO Henrik Busch-Larsen. By Q2 2022 the design, construction & installation of a pilot-scale, modular microalgae PhotoBioReactor (PBR) at the Danish Technological Institute had been completed.
Today the pilot project is used to optimize the technology and produce algae product samples for application trials with R&D partners and potential clients.
ALGIECEL has received funding from the BioInnovation Instiute (BII), a DKK 13M seed round and several public grants. Most recently, the ALGIECEL-lead “CAPCO2” consortium including NOVOZYMES & DTU, has received DKK 18M in grant financing from EUDP for ALGIECEL´s first full-scale demonstration project.
A highly skilled & experienced team of 14 people has been built in Copenhagen and Odense.
ALGIECEL has entered into supplier agreements with partners that hold key insights into areas such as LED light, biotech and plastic.
LOIs with potential CO2 feedstock suppliers and product end-users have been secured.
THE PILOT PROJECT
In June 2022 ALGIECEL celebrated the opening of the mobile pilot plant at the Danish Technological Institute with more than 70 participants.
The day was dedicated to the green transition and sustainability with ALGIECEL´s development of a mobile container-based solution for the conversion of CO2 into biomass.
The pilot photobioreactor is now set up in cooperation with the DTI, which has secured access to laboratories, facilities and competencies within the microalgae cultivation area.
CEO Juan Farré from the DTI stated that “the opening marks the establishment by the DTI of an ecosystem giving start-up companies access to an integrated platform of testing and demonstration facilities within the space of future foods and the green transition”.
Earlier this year BII invested in ALGIECEL, and during the opening ceremony Jens Nielsen, the CEO of BII, kindly remarked: “I am impressed to see how rapidly ALGIECEL has advanced and is now initiating experiments at pilot scale. But speed is unfortunately important as we rapidly need new technologies like the ones ALGIECEL is providing to make sure that we can create a sustainable society. I congratulate them with their advancements, and I will be looking much forward to following them in the years to come”.
Meet the Management & Board
Management Team

Henrik Busch-Larsen
CEO / Founder / Board Member
Entrepreneur, Strategy, Vision, Execution, Scale-up
Prior experience with
CEO Unibio Group, Co-founder A21 Systems, Various Board Positions

Jesper Svarer
CFO
Experience from international senior leadership roles within Finance, Strategy, M&A and business development.
Prior experience with:
Falck, KMD, A.P. Moller-Maersk, ISS, Handelsbanken

Christian Kølby
CTO
Civil Engineer, MSc., Biotechnology and Aquaculture
Prior experience with:
Nestlé, SPX, Arla Foods Ingredients, Danisco, professional experience with pilot plants, R&D, food application technology and product management

Gry Husby Larsen
SVP Legal & HR
Lawyer, General Counsel
Prior experience with:
FluoGuide, BioPorto, Unibio, Knop & Co Advokater, DTU, Rigshospitalet
Board of Directors

Tina Moe
Chairperson of the Board
CEO @Leadership of the Future
Prior experience with:
DTU, Alectia, Art District, NNE, Novo Nordisk, several board and chair positions

Martin Lavesen
Board Member
Managing Partner @DLA Piper Denmark
Prior experience with:
+25 years as commercial lawyer focusing on IPR, Various board positions

Jeppe Høier
Board Member
Investor
Investor background from: Sunstone Life Science Ventures, Heartcore Maersk Growth. Led Unicorn rounds in companies such as Einride and Forto

Henrik Busch-Larsen
CEO / Founder / Board Member
Entrepreneur, Strategy, Vision, Execution, Scale-up
Prior experience with
CEO Unibio Group, Co-founder A21 Systems, Various Board Positions

Merete Lundbye Møller
Board Member
Venture Partner & General Counsel @Sunstone Life Science Ventures
Prior experience with:
PreSeed Ventures, Curo Capital, Vækstfonden, Danish Green Investment Fund, Warehouse9, Hotel Pro Forma, Nalik Ventures
Advisory Board

Per Møller
Senior Symbiosis Developer @Kalundborg Symbiosis
Industrial Symbiosis, Marine Biology, Microalgae downstream processing, Chemical Engineering

Dr. Dorinde Kleinegris
Principal Investigator Microalgae @NORCE, Associate Prof. Marine Biotechnology at the University of Bergen (secondary position)
Bioprocess Engineering, Microalgae cultivation & strain selection, Techno-economic & LCA

Stephan Freyer
Senior Research Manager @BASF
Bioprocess Development, Scale-Up, Fermentation, Media Optimization

Dr. Andreas Worberg
CCO @The Novo Nordisk Foundation Center for BiosustainabilityCCO @DTU Biosustain, CTO @Cellugy ApS
Process Development in Biomanufacturing, Business Development

Michael Stannius Aagren
Digitalization Manager @Unibio
Industrial Production, Digitalization & IT
THE VALUE STATEMENTS
Good work life balance supported by ownership mentality
We strive towards avoiding a hard-core nine-to-five work culture and at the same time we want to create space for everybody to thrive in their personal lives. A good work-life balance is to the benefit of everyone. We want to promote a high-level of responsibly for tasks and deadlines. In some instances, work may be required in the evenings and during weekends, however we expect that periods with high stress levels will be followed by periods of recuperation and self-maintenance.
Not bound by business as usual
Our culture should emphasize the willingness to take well-understood risk and to explore new approaches to all sorts of challenges. Our culture should embrace swift adaptability when a situation requires it and the ability to pivot from existing methods to new solutions if opportunities show up.
Trust and support are the pillars of a strong team
Our culture should enable a high level of trust and openness between team members. We want to build a collaborative and supportive culture where people by default wish to help and assist team members.
Planetary health is in everybody´s interest
We want to build a culture where we always strive towards applying sustainable solutions to all technology and business-related challenges. We consider us part of a global ecosystem that needs to thrive to allow all subsystems to thrive too.
.
Customer service is in our DNA
We want a culture geared towards delivering easily implementable technological solutions and products to our clients. Delivering carbon capture as a service requires that everyone brings service mindedness up front. Our culture should embody our efforts to address some of the biggest challenges of our time; Namely, how to capture CO2 from industrial processes and utilize it to produce valuable sustainable products while adding to our clients´ bottom line.
Remember to have fun
Work must be serious at times; however, it should be fun most of the time! We must remember to celebrate our successes and learn from our mistakes.
DIVERSITY POLICY
Algiecel is committed to continue working towards ensuring and furthering equal opportunities for all employees in respect of differences, such as gender, age, religion, sexual orientation and ethnicity, as all – in our view – serve as key components in ensuring a better, more dynamic and healthier business.
The view extended through this policy also includes maintaining equal opportunities for women and men at all management levels in Algiecel. The Board of Directors annually discusses the company’s activities to ensure relevant diversity at management levels and evaluates the policy on diversity.
Algiecel has defined a target, that no later than in 2025, at the composition of genders shall be no less than 25%/75% both in the Management of the Company and Board of Directors. This target must not detract from other competency requirements in the nomination of members to the Management team of the Company.